2.0875
-0.1450
(-6.49%)
At close: January 10 at 5:26:08 PM GMT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 1 | 1 |
| Avg. Estimate | 0 | 0 | -0.03 | -0.01 |
| Low Estimate | 0 | 0 | -0.03 | -0.01 |
| High Estimate | 0 | 0 | -0.03 | -0.01 |
| Year Ago EPS | -- | -- | -0.04 | -0.03 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | -- | -- | -- | -- |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | -0.03 | -0.01 |
| 7 Days Ago | 0 | 0 | -0.03 | -0.01 |
| 30 Days Ago | 0 | 0 | -0.03 | -0.01 |
| 60 Days Ago | 0 | 0 | -0.03 | -0.01 |
| 90 Days Ago | 0 | 0 | -0.03 | -0.01 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| SNG.L | -- | -- | 22.38% | 50.02% |
| S&P 500 | 8.70% | 11.55% | 14.03% | 13.42% |
Related Tickers
AVCT.L Avacta Group Plc
51.00
0.00%
SCLP.L Scancell Holdings plc
10.10
+3.59%
OPTI.L OptiBiotix Health Plc
17.50
0.00%
FARN.L Faron Pharmaceuticals Oy
200.00
0.00%
IMM.L ImmuPharma plc
3.5500
+1.43%
0EVI.IL Innate Pharma S.A.
1.8190
+2.19%
0QAJ.IL DBV Technologies S.A.
0.8715
-22.19%
0RQE.IL Idorsia Ltd
0.7725
-2.71%
PYC.L Physiomics Plc
0.8250
0.00%
AREC.L Arecor Therapeutics plc
58.50
-20.95%